Skip to main content

Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology: A Workshop

Completed

This 2015 workshop featured presentations and panel discussions regarding use of advanced technologies for radiation therapy and surgery in cancer diagnosis and treatment. Topics included: clinical benefits and comparative effectiveness of emerging technologies for cancer treatment in radiation and surgery; current utilization patterns of radiation and surgical technologies in oncology practice; evidence on the overuse, underuse, and misuse of these technologies; and potential strategies to assess the value and define optimal use of new medical technologies in cancer treatment.

Description

An ad hoc committee will plan and host a 1.5-day public workshop that will feature invited presentations and panel discussions. Workshop participants will be invited to discuss topics that may include:

  • the clinical benefits and comparative effectiveness of emerging advanced technologies for cancer treatment in radiation and surgery;
  • current utilization patterns, especially diffusion of new radiation and surgical technologies, in oncology practice;
  • evidence on the overuse, underuse, and misuse of these technologies; and
  • potential strategies to assess the value and define optimal use of new medical technologies in cancer treatment.

The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. An individually-authored workshop summary of the presentations and discussions at the workshop will be prepared by a designated rapporteur based on the information gathered and the discussions held during the workshop in accordance with institutional guidelines

Collaborators

Sponsors

Abbott Laboratories

American Association for Cancer Research

American Cancer Society

American Society for Radiation Oncology

American Society of Clinical Oncology

American Society of Hematology

Association of American Cancer Institutes

AstraZeneca

Bristol Myers Squibb

Cancer Support Community

Centers for Disease Control and Prevention (CDC)

CEO Roundtable on Cancer

EMD Serono

Helsinn Therapeutics (U.S.), Inc.

LiveSTRONG Foundation

National Cancer Institute

National Comprehensive Cancer Network

National Institutes of Health

Novartis Oncology

Oncology Nursing Society

Pfizer Inc.

Staff

Sharyl Nass

Lead

Erin Balogh

Lead

Patrick Burke

Cyndi Trang

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.